Hearken to this textVCA Animal Hospitals, a world chief of complete veterinary companies and a part of Mars Veterinary Well being, just lately introduced the appointment of Patty Wu as president, efficient Could 2024. Wu succeeds Todd Lavender, DVM, who, following a profitable 20 years at VCA, will develop into chief transformation officer of Mars Veterinary Well being.
“I’ve had the pleasure of working alongside Dr. Lavender for a few years, and all through this time, he’s inspired our groups to guide in medical high quality, unfold the enjoyment of our career and innovate for our purchasers,” stated Doug Drew, president, Mars Veterinary Well being. “As chief transformation officer, Todd will sharpen our future focus throughout our community, persevering with to do extra in the present day to enhance the expertise of pet possession and the expertise of these caring for pets tomorrow.”
Drew continued: “I’m thrilled to welcome Patty to VCA and the Mars Veterinary Well being household. As an achieved senior government with greater than 20 years of expertise main and rising CPG, omni retail, and direct-to-consumer companies within the U.S., Canada, China and Asia Pacific, Patty believes distinctive shopper and affected person outcomes develop from a robust Affiliate and shopper expertise.”
Wu comes with a observe file of robust execution and constant deal with the affiliate and shopper expertise throughout classes starting from well being and wellness to child and kids, and private care. She has held senior roles at firms together with Mattress, Bathtub & Past, the place she served as EVP and brand president for buybuy BABY, in addition to The Sincere Firm, The Clorox Firm, Walmart, Mattel and Beautycounter.
Wu commented: “Over the previous few years, VCA has expanded entry to care, skilled wonderful development and stayed true to an Affiliate-first, pet-centric tradition. I’m excited and honored to hitch a company with such readability of mission and objective.”
As chief transformation officer, Dr. Lavender will lead packages designed to extend entry to care and encourage the subsequent technology of veterinary professionals.
Reflecting on VCA, Dr. Lavender provides: “We’re severe about our obligation of caring for the way forward for veterinary drugs. We have now expanded entry to care throughout the U.S., and to Canada and Brazil, strengthened the affiliate expertise and continued to scale the highest-quality drugs for our sufferers. Patty is becoming a member of a community of hometown hospitals that places affected person outcomes, compassion and shopper expertise on the heart of all the things we do. We welcome Patty to VCA.”
